<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02284932</url>
  </required_header>
  <id_info>
    <org_study_id>COPD-20739</org_study_id>
    <nct_id>NCT02284932</nct_id>
  </id_info>
  <brief_title>Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>Muscle Atrophy In Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Limb muscle dysfunction, characterized by atrophy and weakness, is amongst the most
      troublesome systemic consequences of chronic obstructive pulmonary disease (COPD) leading to
      poor functional status and premature mortality.

      One prevailing hypothesis stipulates that the deterioration in muscle structure and function
      during COPD results from a spillover of inflammatory mediators from the lungs to the systemic
      circulation and then to the muscles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators objective is to investigate the impact of COPD on key signaling pathways
      involved in the muscle atrophy. Moderate to severe COPD patients (FEV1 under 60% of
      predicted) and healthy controls will be recruited. All of the investigators patients will
      undergo a thorough baseline assessment in pulmonary capacity, muscle force and body
      composition. Blood sampling and biopsy of the quadriceps will be done. Key proteins of
      signaling intramuscular pathways involved in protein synthesis and degradation will be
      measured in the quadriceps.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Weeks</target_duration>
  <primary_outcome>
    <measure>Decrease of protein degradation in muscles of wasted COPD patients</measure>
    <time_frame>At baseline (COPD in a stable state of the disease)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase of protein synthesis in muscles of wasted COPD patients</measure>
    <time_frame>At baseline (COPD in a stable state of the disease)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>COPD patients</arm_group_label>
    <description>Group : COPD patients No specific intervention for this study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Group : healthy volunteers No specific intervention for this study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No specific intervention for this study</intervention_name>
    <description>No specific intervention for this study</description>
    <arm_group_label>COPD patients</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample and muscle biopsy of vastus lateralis (quadriceps)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with COPD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male

          -  COPD with an FEV1 of under 60% of predicted

          -  non-smoker

          -  between 55 and 75 years old

        Exclusion Criteria:

          -  all inflammatory disease (HIV, cancer, renal and cardiac deficiency)

          -  hormonal dysregulation

          -  inferior limb pathology

          -  neuromuscular pathology

          -  history of tobacco or alcool abuse

          -  oxygen dependent

          -  recent exacerbation (2 months) of the symptoms of COPD
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Maltais, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut universitaire de cardiologie et de pneumologie de Québec</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2014</study_first_submitted>
  <study_first_submitted_qc>November 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2014</study_first_posted>
  <last_update_submitted>September 7, 2016</last_update_submitted>
  <last_update_submitted_qc>September 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Annie Dubé</investigator_full_name>
    <investigator_title>Professionelle de recherche</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>atrophy</keyword>
  <keyword>muscle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

